AI assistant
Annexon, Inc. — Director's Dealing 2021
Jun 7, 2021
33181_dirs_2021-06-07_339db897-fc33-4723-b291-8409533cfad5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Annexon, Inc. (ANNX)
CIK: 0001528115
Period of Report: 2021-06-03
Reporting Person: Yednock Ted (EVP & Chief Scientific Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-03 | Common Stock | M | 15000 | $1.4096 | Acquired | 15000 | Direct |
| 2021-06-03 | Common Stock | S | 12816 | $21.4485 | Disposed | 2184 | Direct |
| 2021-06-03 | Common Stock | S | 2184 | $21.7220 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-03 | Stock Option (Right to Buy) | $1.4096 | M | 15000 | Disposed | 2025-01-22 | Common Stock (15000) | Direct |
Footnotes
F1: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2: This transaction was executed in multiple trades in prices ranging from $20.67 to $21.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: This transaction was executed in multiple trades in prices ranging from $21.665 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: The shares subject to the option vest are fully vested and exercisable.